Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-09 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 200,00k | 108,58k | Kauf | 0,54 | 20,25M | 1,00% |
| 2026-06-02 | Morgan StanleyUnternehmen | -96,25k | 0,00 | Other Disposition | - | 71,81M | -0,13% |
| 2026-06-05 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 200,00k | 121,38k | Kauf | 0,61 | 20,05M | 1,01% |
| 2026-06-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 105,00k | 65,35k | Kauf | 0,62 | 19,85M | 0,53% |
| 2026-05-13 | Morgan StanleyUnternehmen | -2,00M | 0,00 | Other Disposition | - | 61,66M | -3,14% |
| 2026-05-08 | Dr. Wei LiNon-Executive Chairman | 500,00k | 0,00 | Derivative Exercise and Retained Stock | - | 979,16k | 104,35% |
| 2026-04-23 | Morgan StanleyUnternehmen | -9,06M | 0,00 | Other Disposition | - | 53,84M | -14,41% |
| 2026-04-15 | Morgan StanleyUnternehmen | 7,96M | 9,63M | Kauf | 1,21 | 57,00M | 16,23% |
| 2026-04-15 | Hillhouse Investment Management, Ltd.Unternehmen | 26,20M | 30,00M | Kauf | 1,14 | 88,66M | 41,94% |
| 2026-04-02 | GIC Private LimitedUnternehmen | -2,52M | 2,97M | Verkauf | 1,18 | 87,17M | -2,81% |
| 2026-03-27 | GIC Private LimitedUnternehmen | -12,41M | 12,87M | Verkauf | 1,04 | 103,23M | -10,73% |
| 2026-03-26 | GIC Private LimitedUnternehmen | -3,02M | 2,73M | Verkauf | 0,90 | 115,65M | -2,54% |
| 2026-03-04 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,95M | 1,08% |
| 2026-03-04 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 479,16k | 4,55% |
| 2026-03-04 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 26,76k | 20,45k | Derivative Exercise and Retained Stock | 0,76 | 19,74M | 0,14% |
| 2026-03-04 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -12,62k | 0,00 | Derivative Exercise and Sale | 0,76 | 19,74M | - |
| 2026-02-04 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,93M | 1,09% |
| 2026-02-04 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 458,33k | 4,76% |
| 2026-02-04 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -9,51k | 6,31k | Derivative Exercise and Sale | 0,66 | 19,72M | - |
| 2026-01-22 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 280,00k | 196,58k | Kauf | 0,70 | 19,54M | 1,45% |
| 2026-01-23 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 148,50k | 104,22k | Kauf | 0,70 | 19,69M | 0,76% |
| 2026-01-06 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,91M | 1,10% |
| 2026-01-06 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 437,50k | 5,00% |
| 2026-01-06 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -4,82k | 3,31k | Verkauf | 0,69 | 19,26M | -0,03% |
| 2025-12-23 | GIC Private LimitedUnternehmen | 904,50k | 679,99k | Kauf | 0,75 | 118,89M | 0,77% |
| 2025-12-12 | Mr. Kenneth Walton HitchnerNon Executive Director | 16,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,11M | 0,76% |
| 2025-12-04 | Dr. Zhengguo HuNon-Executive Director | 1.000,00k | 739,45k | Kauf | 0,74 | 1,89M | 112,66% |
| 2025-12-03 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 887,66k | 2,40% |
| 2025-12-03 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 416,66k | 5,26% |
| 2025-12-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 59,50k | 0,00 | Derivative Exercise and Retained Stock | - | 19,23M | 0,31% |
| 2025-12-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -58,63k | 42,31k | Derivative Exercise and Sale | 0,72 | 19,23M | - |
| 2025-11-14 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 40,00k | 31,60k | Kauf | 0,79 | 19,17M | 0,21% |
| 2025-11-12 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 70,00k | 49,45k | Kauf | 0,71 | 19,01M | 0,37% |
| 2025-11-13 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 117,50k | 81,93k | Kauf | 0,70 | 19,13M | 0,62% |
| 2025-11-11 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 100,00k | 68,78k | Kauf | 0,69 | 18,94M | 0,53% |
| 2025-11-05 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 866,83k | 2,46% |
| 2025-11-05 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 395,83k | 5,56% |
| 2025-11-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 220,00k | 177,59k | Kauf | 0,81 | 18,84M | 1,18% |
| 2025-10-20 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 400,00k | 347,06k | Kauf | 0,87 | 18,32M | 2,23% |
| 2025-10-21 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 300,00k | 276,42k | Kauf | 0,92 | 18,62M | 1,64% |
| 2025-10-13 | GIC Private LimitedUnternehmen | 2,26M | 2,02M | Kauf | 0,89 | 88,62M | 2,62% |
| 2025-10-03 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 846,00k | 2,52% |
| 2025-10-03 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 375,00k | 5,88% |
| 2025-09-25 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 150,00k | 150,34k | Kauf | 1,00 | 17,92M | 0,84% |
| 2025-09-11 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -6,54M | 0,00 | Open Market Derivative Disposition | - | - | - |
| 2025-09-09 | Mr. Kenneth Walton HitchnerNon Executive Director | -500,00k | 818,58k | Verkauf | 1,64 | 2,10M | -19,25% |
| 2025-09-08 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -100,00k | 0,00 | Open Market Derivative Disposition | - | - | - |
| 2025-09-04 | Dr. Zhengguo HuNon-Executive Director | -227,00k | 350,07k | Verkauf | 1,54 | 1,05M | -17,80% |
| 2025-09-05 | Dr. Zhengguo HuNon-Executive Director | -223,00k | 343,45k | Verkauf | 1,54 | 825,17k | -21,28% |
| 2025-09-03 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,28M | 1,66% |
| 2025-09-03 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 354,17k | 6,25% |
| 2025-09-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -39,38k | 61,03k | Verkauf | 1,55 | 17,77M | -0,22% |
| 2025-08-20 | Morgan StanleyUnternehmen | -107,67M | 0,00 | Other Disposition | - | 67,70M | -61,40% |
| 2025-08-18 | GIC Private LimitedUnternehmen | 80,40M | 81,24M | Kauf | 1,01 | 80,40M | - |
| 2025-08-15 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -118,13k | 0,00 | Open Market Derivative Disposition | - | - | - |
| 2025-08-20 | 6 Dimensions Capital LimitedUnternehmen | -120,00M | 121,35M | Verkauf | 1,01 | 173,38M | -40,90% |
| 2025-08-05 | Dr. Zhengguo HuNon-Executive Director | 41,67k | 0,00 | Derivative Exercise and Retained Stock | - | 1,25M | 3,44% |
| 2025-08-05 | Dr. Wei LiNon-Executive Chairman | 41,67k | 0,00 | Derivative Exercise and Retained Stock | - | 333,33k | 14,29% |
| 2025-07-16 | Morgan StanleyUnternehmen | -83,00M | 0,00 | Other Disposition | - | 56,56M | -59,47% |
| 2025-07-14 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 10,00k | 6,62k | Kauf | 0,66 | 17,77M | 0,06% |
| 2025-07-10 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,21M | 1,75% |
| 2025-07-10 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 291,67k | 7,69% |
| 2025-06-26 | Dr. Wei LiNon-Executive Chairman | 270,83k | 0,00 | Derivative Exercise and Retained Stock | - | 270,83k | - |
| 2025-06-26 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,19M | 1,78% |
| 2025-06-26 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 39,38k | 0,00 | Derivative Exercise and Retained Stock | - | 17,76M | 0,22% |
| 2025-06-10 | Boyu Capital Group Management Ltd.Unternehmen | -68,55M | 35,02M | Verkauf | 0,51 | 40,02M | -63,14% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
